REMISSION INDUCTION IN PATIENTS WITH LYMPHOID MALIGNANCIES USING UNCONJUGATED CAMPATH-1 MONOCLONAL-ANTIBODIES

REMISSION INDUCTION IN PATIENTS WITH LYMPHOID MALIGNANCIES USING UNCONJUGATED CAMPATH-1 MONOCLONAL-ANTIBODIES

Detalhes bibliográficos
Main Authors:	Dyer, M, Hale, G, Marcus, R, Waldmann, H
Formato:	Journal article
Publicado em:	1990

Registos relacionados

Effects of CAMPATH-1 antibodies in vivo in patients with lymphoid malignancies: influence of antibody isotype.
Por: Dyer, M, et al.
Publicado em: (1989)

Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H.
Por: Hale, G, et al.
Publicado em: (1988)

Specificity of monoclonal antibody Campath-1.
Por: Hale, G, et al.
Publicado em: (1988)

CAMPATH-1 monoclonal antibodies in bone marrow transplantation.
Por: Hale, G, et al.
Publicado em: (1994)

Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nonmyeloablative conditioning?
Por: Hale, G, et al.
Publicado em: (2002)

EFFECTS OF MONOCLONAL-ANTIBODIES OF THE CAMPATH SERIES INVIVO - REQUIREMENTS FOR EFFECTIVE ANTIBODY THERAPY
Por: Dyer, M, et al.
Publicado em: (1988)

CAMPATH-1 monoclonal antibody therapy in severe refractory autoimmune thrombocytopenic purpura.
Por: Lim, S, et al.
Publicado em: (1993)

Monoclonal antibody therapy of diffuse cutaneous scleroderma with CAMPATH-1H.
Por: Isaacs, J, et al.
Publicado em: (1996)

Engraftment of marrow allografts treated with Campath-1 monoclonal antibodies.
Por: Naparstek, E, et al.
Publicado em: (1999)

Reversal of allograft rejection using the monoclonal antibody, Campath-1G.
Por: Friend, P, et al.
Publicado em: (1991)

Rat monoclonal antibodies for bone marrow transplantation--the CAMPATH series.
Por: Waldmann, H, et al.
Publicado em: (1985)

ISOTYPE VARIANTS OF CAMPATH-1 ANTIBODY - REQUIREMENTS FOR EFFECTIVE ANTIBODY ACTION INVIVO
Por: Dyer, M, et al.
Publicado em: (1989)

Monoclonal antibody therapy of chronic intraocular inflammation using Campath-1H.
Por: Isaacs, J, et al.
Publicado em: (1995)

Sustained remission of severe resistant autoimmune neutropenia with Campath-1H.
Por: Killick, S, et al.
Publicado em: (1997)

RAT MONOCLONAL-ANTIBODIES FOR BONE-MARROW TRANSPLANTATION (BMT) - THE CAMPATH SERIES
Por: Waldmann, H, et al.
Publicado em: (1985)

Reply: In vitro and in vivo anticancer efficacy of unconjugated humanised anti-CEA monoclonal antibodies
Por: Ashraf, S, et al.
Publicado em: (2008)

Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy.
Por: Lockwood, C, et al.
Publicado em: (1993)

Monoclonal antibodies and lymphoid leukaemias.
Por: Beverley, P
Publicado em: (1984)

Anti-globulin responses to rat and humanized CAMPATH-1 monoclonal antibody used to treat transplant rejection.
Por: Rebello, P, et al.
Publicado em: (1999)

Availability of Campath-1 antibodies for bone marrow transplantation.
Por: Hale, G, et al.
Publicado em: (1995)

Pilot study of CAMPATH-1, a rat monoclonal antibody that fixes human complement, as an immunosuppressant in organ transplantation.
Por: Hale, G, et al.
Publicado em: (1986)

Campath-1 Abs 'in the bag' for hematological malignancies: the Cape Town experience.
Por: Novitzky, N, et al.
Publicado em: (2004)

Prevention of immune-mediated corneal graft destruction with the anti-lymphocyte monoclonal antibody, CAMPATH-1H.
Por: Newman, D, et al.
Publicado em: (1995)

Appropriate targets for monoclonal antibodies in the induction of transplantation tolerance.
Por: Waldmann, H, et al.
Publicado em: (2001)

Impact on T-cell depletion and CD34+ cell recovery using humanised CD52 monoclonal antibody (CAMPATH-1H) in BM and PSBC collections; comparison with CAMPATH-1M and CAMPATH-1G.
Por: Williams, R, et al.
Publicado em: (2000)

Reactivity of rat monoclonal antibody CAMPATH-1 with human leukaemia cells and its possible application for autologous bone marrow transplantation.
Por: Hale, G, et al.
Publicado em: (1985)

Monoclonal antibodies for the induction of transplantation tolerance.
Por: Waldmann, H, et al.
Publicado em: (1993)

The CAMPATH-1 antigen (CDw52).
Por: Hale, G, et al.
Publicado em: (1990)

Induction of tolerance by monoclonal antibody therapy.
Por: Benjamin, R, et al.
Publicado em: (1986)

Monoclonal antibodies for the therapeutic induction of tolerance.
Por: Waldmann, H, et al.
Publicado em: (1993)

CAMPATH-1 antibodies in stem-cell transplantation.
Por: Hale, G, et al.
Publicado em: (2001)

Recent results using CAMPATH-1 antibodies to control GVHD and graft rejection.
Por: Hale, G, et al.
Publicado em: (1996)

Control of graft-versus-host disease and graft rejection by T cell depletion of donor and recipient with Campath-1 antibodies. Results of matched sibling transplants for malignant diseases.
Por: Hale, G, et al.
Publicado em: (1994)

ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA USING CAMPATH-1 MONOCLONAL-ANTIBODIES AND POSTTRANSPLANT ALLOIMMUNIZATION WITH DONOR LYMPHOCYTES
Por: Naparstek, E, et al.
Publicado em: (1993)

Tolerance induction with CD4 monoclonal antibodies.
Por: Waldmann, H, et al.
Publicado em: (1998)

A personal history of the CAMPATH-1H antibody.
Por: Waldmann, H
Publicado em: (2002)

TREATMENT OF RHEUMATOID-ARTHRITIS WITH HUMANIZED ANTILYMPHOCYTE ANTIBODY CAMPATH-1H
Por: Watts, R, et al.
Publicado em: (1992)

Monoclonal antibodies for immunosuppression.
Por: Waldmann, H, et al.
Publicado em: (1988)

Induction of tolerance in peripheral T cells with monoclonal antibodies.
Por: Qin, S, et al.
Publicado em: (1990)

MONOCLONAL-ANTIBODIES FOR CONDITIONING PRIOR TO MARROW TRANSPLANTATION
Por: Hale, G, et al.
Publicado em: (1989)